Doctors are not safe with some patients.

Published Date: 16 Feb 2023

Many physicians have encountered one or more serious or potentially dangerous patients over the years, and according to Medscape research, patient trust has declined.

Read Full News

Latest News

Will a Smart Toilet Turn the Home Into a Diagnostic Center?

Smart toilets show promise for passive monitoring of stool and urine to detect potential health issues, but challenges remain.

Bayer Sues Johnson & Johnson Over Claim That Prostate Cancer Drug Cuts Risk Of Death

Bayer sued Johnson & Johnson on Monday, accusing the drugmaker of falsely advertising that its rival multibillion-dollar drug cuts the ⁠risk of death from prostate...

Doc Murdered 8 Patients? RFK Jr. Will 'Cost Lives'; $412M in Penile Injection Case

Health news and commentary gathered by MedPage Today staff

FDA Approves Novel Treatment for UTIs

New oral antibiotic gets a nod for uncomplicated urinary tract infections

Mission Health Urologists Disappear.

Following the takeover by HCA, experts identify the most recent departures.

More then ever, the healthcare industry needs qualified expert witnesses.

It can offer a fresh challenge as well as be the appropriate course of action in certain situations.

Todays Updates

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

FDA Approves New Drug Combo for RR Multiple Myeloma

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

Todays Updates

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

FDA Approves New Drug Combo for RR Multiple Myeloma

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

Latest News

Smart toilets show promise for passive monitoring of stool and urine to detect potential health issues, but challenges remain.

Bayer sued Johnson & Johnson on Monday, accusing the drugmaker of falsely advertising that its rival multibillion-dollar drug cuts the ⁠risk of death from prostate...

Health news and commentary gathered by MedPage Today staff

New oral antibiotic gets a nod for uncomplicated urinary tract infections

Following the takeover by HCA, experts identify the most recent departures.

It can offer a fresh challenge as well as be the appropriate course of action in certain situations.

News All Time

The new first-line standard for advanced bladder cancer was produced by a landmark trial.

When compared to chemotherapy, enfortumab vedotin-pembrolizumab doubles OS and PFS.

Should Patients With Advanced Prostate Cancer Get Off the Active Surveillance Train?

Clearly defined rules are needed.

Even in those with HIV, a single dose of antibiotics was able to cure early syphilis.

In a randomized trial, one dosage showed no worse results than a triple-dose regimen.

Removing Cancer Survivors From Oncologic Treatment.

A new approach to care is required.

Cabazitaxel Lower-Dose Schedule Is Viable for Elderly Patients With mCRPC.

Neutropenia of grade three or above, with a twelve-fold reduction in neutropenic consequences.

AR-Pathway Inhibitor Switch for mCRPC is Superseded by Radionuclide Therapy.

With 177Lu-PSMA-617, the time to radiographic progression was doubled.

An RCT Supports HIF-2a Inhibition in Advanced RCC.

Belzutifan outperforms everolimus in the event of immunotherapy-TKI failure.

CAR T-Cell Therapy for Renal Cell Carcinoma: "We're Not There Yet".

Possibility of standard of care following current therapies, but significant barriers still need to be overcome.

Finding New Routes to Improve Renal Cell Carcinoma Outcomes.

It is necessary to intervene at several stages of the cancer immunity cycle in order to build on recent successes.

In severe cases of renal cell carcinoma, tyrosine kinase inhibitor activity is present.

Reactions to the "special medication" zanzalintinib in patients exposed and not exposed to cabozantinib.

Dietary inflammation is associated with the development of urologic cancers.

In health research, the relationship between dietary habits and cancer risks is still a major focus. The has been the subject of a recent meta-analysis.

In infants, laparoscopic robotic pyeloplasty is safe and has a success rate comparable to open surgery.

The results of minimally invasive pyeloplasty (MIP) for the primary cause, ureteropelvic junction obstruction (UPJO), were examined in a recent study.

Medical Bulletin November 30, 2023.

The top medical stories of the day are as follows: ADHD increases the risk of car crashes in older adults. ADHD is a neurodevelopmental disorder that is chronic and has symptoms.

Wellness Bulletin 25/November/2023.

Here are the top health stories for the day:Doctors performing 'Two Finger Test' will be guilty of misconductReiterating the fact that the Supreme.

The only viable solution for stress urinary incontinence with mesh slings is informed decision-making.

UK: A recent study thoroughly examined the short- and long-term mesh sling complications reported in European Urology Focus.

Black people who consume a few servings of whole grains have been shown to experience a slower rate of memory loss.

A slower rate of memory loss may be experienced by Black individuals who consume more whole grain-containing foods, such as popcorn, quinoa, and some breads and cereals.

Recommended News For You

Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC

Oleanolic acid from grapes may increase chemotherapy effectiveness

Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer

Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer

novel technique for early myelodysplastic syndrome relapse detection in blood cancer patients.

Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma

MCh in Surgical Oncology: Admission, Medical School, Fees, Qualifications Information

Recommended Articles For You

The Importance of Iron Rich Foods in Preventing and Treating Anemia  

Unlocking the Secrets of Ringed Sideroblasts: A New Frontier in Hematology 

Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL 

Introduction to Immune Thrombocytopenic Purpura 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Top Cancer Centers; Phase III Win in Prostate Cancer; Screening Recs for Anal Cancer

2.

Acupuncture may alleviate nocturia in men treated for prostate cancer

3.

Healthcare AI, Meant to Save Money, Turns Out to Require a Lot of Expensive Humans

4.

Could CT scans be fueling a future rise in cancer cases, as a new study suggests?

5.

Study finds 20 minutes of mindful breathing can rapidly reduce intensity of cancer pain

1.

Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer

2.

Unlocking The Power Of Cangrelor To Treat Heart Disease

3.

Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review

4.

Uncovering the Role of Pap Smear in Oncology: A New Frontier in Cancer Detection

5.

Unveiling the Secrets of Early Cancer: Emerging Strategies to Decipher Its Biology

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.

2.

Efficient Management of First line ALK-rearranged NSCLC - Part VI

3.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

4.

Navigating the Complexities of Ph Negative ALL - Part VII

5.

Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot